Journal profile · Ophthalmology
Ophthalmologica
ISSN 0030-3755 · eISSN 1423-0267 · S. Karger AG · SWITZERLAND · Bimonthly · Founded 1938
Ophthalmologica: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.24; hybrid open access; median 173 days to acceptance (89 articles, last 24 months); community-reported acceptance: about 75%; 40 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Ophthalmologica is published by S. Karger AG and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Glaucoma and retinal disorders, Retinal Diseases and Treatments and Medical and Health Sciences Research, together about 24.1% of its articles. Its main subfields are Ophthalmology. (generated from OpenAlex topic counts and CAS ranking data)
Established since 1899, Ophthalmologica is a frequently cited guide to research in clinical and experimental ophthalmology with a large international circulation and international readership. It contains a selection of patient-oriented contributions covering the etiology of eye diseases, diagnostic techniques, and advances in medical and surgical treatment, with special emphasis on retinal diseases. In addition to original research, the journal regularly features timely reviews to help the readers stay up to date.
From the journal's Aims & Scope
Research area (LetPub): Ophthalmology
Editor-in-chief Martin ZinkernagelPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Glaucoma and retinal disordersMedicine10.7%
- Retinal Diseases and TreatmentsMedicine7.2%
- Medical and Health Sciences ResearchMedicine6.2%
- Medical History and ResearchArts and Humanities5.1%
- Intraocular Surgery and LensesMedicine5.1%
- Retinal and Macular SurgeryMedicine5%
- Ocular Diseases and Behçet’s SyndromeMedicine4.8%
- Biomedical and Chemical ResearchMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Ophthalmology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Ophthalmology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Ophthalmology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.24LetPub ·
- Impact factor (publisher)
- 2.3Publisher website ·
- CiteScore 2026-06
- 3.9LetPub ·
- CiteScore (publisher)
- 3.9Publisher website ·
- SJR 2026-06
- 0.77LetPub ·
- SNIP 2026-06
- 0.96LetPub ·
- h-index
- 54LetPub ·
- h-index
- 94OpenAlex ·
- i10-index
- 2,698OpenAlex ·
- 2-year mean citedness
- 1.98OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 23.21%LetPub ·
Volume
- Articles per year
- 38LetPub ·
Articles by year OpenAlex count · 15,156 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 35 | 10 | 1 |
| 2025 | 40 | 19 | 61 |
| 2024 | 40 | 20 | 166 |
| 2023 | 44 | 14 | 241 |
| 2022 | 52 | 24 | 320 |
| 2021 | 72 | 30 | 820 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
173 daysMedian, submission to acceptance · P25–P75 120 days – 202 days
- Acceptance to online
- median 17 days (89 articles)
- Submission to online
- median 197 days
- Sample
- 89 articles with submission and acceptance dates (94 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Acceptance rate (publisher)
- 18.1%Publisher website ·
- Submission to first decision
- 31 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteSelf-archiving
- Self-archiving
Official journal of the European Society of Retina Specialists (EURETINA) Model summary
Ophthalmologica is the official journal of the European Society of Retina Specialists (EURETINA).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- S. Karger AG
- Country or region
- SWITZERLAND
- Language
- Multi-Language
- Frequency
- Bimonthly
- Founded
- 1938
- ISSN
- 0030-3755
- Electronic ISSN
- 1423-0267
- Latest issue on the website
- Volume 249, Issue 3 (June 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Ophthalmologica
What CAS zone is Ophthalmologica in?
In the 2025 upgraded edition of the CAS Journal Ranking, Ophthalmologica is in Zone 4 of Medicine, and in Zone 4 of the minor category Ophthalmology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Ophthalmologica?
The latest impact factor listed by LetPub is 2.24; CiteScore 3.9, h-index 94.
How long does peer review take at Ophthalmologica?
Based on the dates recorded on 89 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 173 days (interquartile range 120–202 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 75%”; the journal's website gives an acceptance rate of 18.1%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Ophthalmologica?
According to LetPub and DOAJ records, Ophthalmologica is indexed in SCIE and Scopus.
Is Ophthalmologica open access, and what is the APC?
Ophthalmologica is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .